Editorial: Manipulation of gut microbiota as a key target to intervene on the onset and progression of digestive system diseases

Front Med (Lausanne). 2022 Aug 29:9:999005. doi: 10.3389/fmed.2022.999005. eCollection 2022.

Ding Shi^{1

2}, Silvia Turroni³, Lan Gong⁴, Wenrui Wu^{1

2}, Howard Chi Ho Yim⁴

¹ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
³ Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
⁴ Microbiome Research Centre, St George and Sutherland Clinical Campus, School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.

No abstract available

Keywords: digestive system diseases; fecal microbiota transplantation; gut microbiota; prognosis; treatment.

Publication types